MedTrace Logo

Molecular Pituitary Imaging Using 18F-FET PET

NCT06584123 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-01-06

No results posted yet for this study

Summary

The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.

Conditions

  • Pituitary Adenoma

Interventions

DIAGNOSTIC_TEST

18F-Fluoro-ethyl-tyrosine (FET) PET

18F-Fluoro-ethyl-tyrosine PET study of the pituitary

Sponsors & Collaborators

Principal Investigators

  • Mark Gurnell, MD, PhD · Cambridge University Hospitals NHS Foundation Trust

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-03
Primary Completion
2026-09-02
Completion
2026-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584123 on ClinicalTrials.gov